Pregabalin Manufacturing Plant Project Report 2026: Cost Analysis, ROI, and Feasibility Insights

Pregabalin Manufacturing Plant Project Report 2026: Market by Region, Market by Application, Key Players, Pre-feasibility, Capital Investment Costs, Production Cost Analysis, Expenditure Projections, Return on Investment (ROI), Economic Feasibility, CAPEX, OPEX, Plant Machinery Cost

Last Updated: October, 2026

Get a Free Plant Cost Sample

Trusted by 200+ Clients

No Report Summary found for given criteria.contact us

Choose What's Right for You

Basic
$2999.00$2699.00
10% OFF
Premium
$3999.00$3399.00
15% OFF
Enterprise
$5999.00$4799.00
20% OFF
View Full Comparison

Pay Via

Mastercard
Wire
VISA
Stripe

About the Author

Vishakha Agrawal profile photo

Vishakha Agrawal

Lead - Social & Development Research

Delivering procurement intelligence and supply chain analytics across healthcare, FMCG, and chemicals sectors, with expertise in cost modeling, vendor mapping, and spend optimization to support data-driven sourcing decisions and procurement outcomes.

Frequently Asked Questions

The indicative CAPEX range is USD 12 million to USD 35 million for a mid-scale plant.

The benchmark plant capacity is a few hundred to a few thousand MT per year.

The global pregabalin market size is expected to be around USD 300 million to USD 600 million, with a CAGR of 5.0% to 5.5% forecast through the early 2030s.

The main segments are neuropathic pain and epilepsy tablets (75% to 85%), anxiety and other approved uses (10% to 18%), other formulations (3% to 8%), and research and reference applications (2% to 4%).

The process involves a multi-step synthesis to build the chiral amino acid core via resolution or asymmetric synthesis, followed by salt formation, crystallization, and purification. Key intermediates include an isovaleraldehyde or nitrile intermediate, a cyanide or malonate source, and a resolving agent.

Cost efficiency depends on securing competitive prices for key intermediates and the resolving agent, which together represent 55% to 70% of total raw material cost. Other costs include solvents, reagents, catalysts, and purification materials.

The multi-step reactors and the resolution, crystallization, and drying systems represent 40% to 50% of the total pregabalin plant setup cost.

Manufacturing costs are primarily driven by key intermediate and resolving-agent prices, which account for around 55% to 70% of raw material costs. Other major factors include solvent and reagent consumption, resolution efficiency, purification losses, energy use, product quality requirements, waste treatment, and plant utilization.

Manufacturing capacity is concentrated in China and India, which are the dominant API producers and exporters. These regions have established pharmaceutical manufacturing infrastructure and supply chains for generic APIs.

Pregabalin manufacturing requires compliance with applicable pharmaceutical GMP, quality, environmental, and controlled-substance handling requirements. For regulated markets, manufacturers may also need FDA- or EMA-related regulatory filings, a Drug Master File (DMF) or equivalent documentation, validated analytical methods, batch records, impurity controls, and regulatory inspections, depending on the market and product status.

Need more help?

  • Get plant-level economics customised to your capacity, technology route, location shortlist, financing assumptions, and expansion plans.
  • We offer interactive Excel cost models and dashboards so you can test scenarios on feedstock, utilities, prices, and margins in seconds.
  • Work directly with expert Procurement Resource analysts for insights on recent market trends, technology shifts, best practices, key risks, pricing, margins, ROI, and relevant standards and regulations.
  • Strengthen your competitive position by using these insights to optimise operations, sharpen sourcing strategies, and maximise profitability.
  • For further assistance, share your requirements with our analysts using the options below, and we will quickly come back with tailored solutions and recommended next steps.

Still Need Help?

Europe & Africa+1 254 254 1750[email protected]
USA & Canada+1 254 254 1750[email protected]
APAC+91 8850629517[email protected]

Compare & Choose the Right Report Version for You

MasterCardwireVisastripe
10% OFF

BASIC

$2999.00

$2699.00

BUY NOW
  • Executive Summary
  • Global Market Snapshot
  • Detailed Process Flow
  • Fixed Cost Analysis
  • Conversion Cost Analysis
  • Variable Cost Analysis
  • Project Details, Requirements and Costs Breakdown
  • Project Economics
  • Report Format
Most Popular
15% OFF

PREMIUM

$3999.00

$3399.00

BUY NOW
  • Executive Summary
  • Global Market Snapshot
  • Detailed Process Flow
  • Fixed Cost Analysis
  • Conversion Cost Analysis
  • Variable Cost Analysis
  • Project Details, Requirements and Costs Breakdown
  • Project Economics
  • Report Format
20% OFF

ENTERPRISE

$5999.00

$4799.00

BUY NOW
  • Executive Summary
  • Global Market Snapshot
  • Detailed Process Flow
  • Fixed Cost Analysis
  • Conversion Cost Analysis
  • Variable Cost Analysis
  • Project Details, Requirements and Costs Breakdown
  • Project Economics
  • Report Format

How to Order Your Report?